Status:

COMPLETED

Quartet™ Bad Oeynhausen Trial

Lead Sponsor:

Heart and Diabetes Center North-Rhine Westfalia

Conditions:

Congestive Heart Failure

Cardiac Resynchronization Therapy

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

Primary objective of this study is to evaluate whether the use of a quadripolar left ventricular (LV) electrode compared to a standard bipolar LV electrode leads to lower non-responder rates in patien...

Eligibility Criteria

Inclusion

  • Indication for CRT-D implantation according to current guidelines
  • Ischemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM)
  • Sinus rhythm
  • NYHA II-IV
  • Age ≥ 18 years
  • Written informed consent to participate in the study

Exclusion

  • Right bundle brunch block
  • Valvular cardiomyopathy
  • Patient receiving a non-transvenous LV electrode
  • Known pregnancy
  • Age \< 18 years
  • Life expectancy \< 1 year
  • Atrial fibrillation / atrial flutter at the time of enrolment
  • Inability to provide informed consent
  • Participation in another study with active therapeutic arm
  • Regular follow-up in the study center within the first 6 months after implantation not guaranteed

Key Trial Info

Start Date :

March 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2018

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT01850264

Start Date

March 1 2013

End Date

December 1 2018

Last Update

January 30 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum

Bad Oeynhausen, Germany, 32545